Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2026-04-09 @ 7:11 AM
Study NCT ID:
NCT00532935
Status:
COMPLETED
Last Update Posted:
2017-06-09
First Post:
2007-09-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0431A-066
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None